Your molecular diagnostics partner from concept to commercialization

Molecular diagnostics comprises a broad array of techniques used for detecting and monitoring disease biomarkers. These include established molecular biology methods such as PCR amplification and gel electrophoresis, as well as more recent approaches like next-generation sequencing and CRISPR-Cas9 gene editing.

The expertise within our MedixMDx team spans every aspect of molecular diagnostics development and manufacturing – all the way from proof-of-concept to release for sale – meaning you can count on us to shorten assay development time and complexity, helping bring your product to market sooner. We work with customers across the globe to develop molecular diagnostics solutions for infectious diseases, genetic testing, personalized medicines, drug discovery, blood screening, veterinary and environmental applications.

Services and support we offer include:

  • Raw material or master mix testing
  • Kits and primer design
  • Pre-clinical testing
  • Quality-control testing
  • Performance testing
  • Kit manufacturing
  • Kit manufacturing readiness assessments
  • Registration support
  • Sales support

These are underpinned by tireless customer support and consolidated supply chain management, making us your preferred partner, whatever the needs of your molecular diagnosics project.

Products and technologies for molecular diagnostics

MedixMDx supplies a comprehensive suite of reagents and services for molecular diagnostics applications, backed by the support of our highly experience team. Our product offering includes nucleic acid extraction reagents, ready mixes, and enzymes, along with buffers, controls, consumables, and clinical specimens, all available at a scale to meet your needs. 

Our capabilities span a wide selection of technologies, including:

  • Polymerase chain reaction (PCR)/quantitative polymerase chain reaction (qPCR)
  • Reverse transcription polymerase chain reacion (RT-PCR)
  • Next generation sequencing (NGS)
  • Isothermal nucleic acid amplification technology (iNaat)
  • CRISPR-Cas9 and TALEN-based gene editing
  • Microarrays
  • Droplet digital polymerase chain reaction (ddPCR).

Additionally, our agile and innovative approach means we can support other platforms as needed, tailoring our workflow to align with our customers' unique requirements.

Increased flexibility for IVD assay development and manufacturing

MedixMDx has recently grown with the acquisition of myPOLS Biotech GmbH, a company focused on developing DNA polymerase-based tests and engineering novel DNA polymerases to enable advanced applications. myPOLS products are fully compliant with IVD regulatory requirements and are used worldwide for applications that include PCR-based food and water testing and monitoring of the COVID-19 response.

Well-known myPOLS product families include:

These are complemented by further mutant DNA polymerases, all of which undergo rigorous validation to ensure optimized interaction in the master mix.

To discuss how we can help deliver on your goals, please get in touch today or email us at


MedixMDx – your partner from concept to commercialization


March 2022 – NEW!

MedixMDx Fast Bst Mix (MX2106) application note

Application note

March 2022 – NEW!

MedixMDx HS Taq DNA Polymerase (MX1102) application note

Application note

November 2021

MedixMDx qRT-Probe Mix (MX2103, MX2104) application note

Application note

November 2021

MedixMDx qProbe Mix (MX2102) application note

Application note

November 2021

MedixMDx qRT-PCR Lyo ready mix (MX6102) application note

Application note

November 2021
Get in touch

To learn more about how we can help you meet your unique needs, please get in touch today or email us at